Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial.
Marina V ShestakovaBoris KvasnikovEkaterina ErinaElena IsachenkoAlexander Andreevnull nullPublished in: BMJ open diabetes research & care (2023)
ISRCTN39549850.